Background Blood coagulation abnormalities play a major role in COVID-19
pathophysiology. However, the specific details of hypercoagulation and anticoagulation …

Abstract Introduction: Coronavirus disease 2019 (COVID-19) infection was declared a
pandemic, causing high mortality and morbidity worldwide. It predisposes patients to both …

This study describes demographics, thrombotic and bleeding events, mortality, and
anticoagulant use among hospitalized patients with COVID-19 in the United States. Premier …

Aims and objectives Despite thromboprophylaxis, some severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) patients develop thrombotic complications with poor …

Objectives To describe the incidence of thromboembolic events in adult patients with severe
COVID-19 and identify clinical and laboratory factors associated with these events. Design …

Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …

Background Arterial and venous thrombosis are reported to be common in critically ill
COVID-19 patients. Method and results This is a national multicenter retrospective …

ABSTRACT BACKGROUND: Venous thromboembolism or extensive thrombosis is relatively
common in patients with severe COVID-19 infection and has been associated with …

2. METHODS This prospective observational study was conducted in a university hospital
after the institutional Ethics Committee approval (N‐124‐2021). Written informed consent …

High rates of thromboembolic events have been described in intensive care unit (ICU)
patients. Data regarding thromboembolic events in all hospitalized patients has been less …